Mechanistic studies indicate that PARP9 interacts with SOX6, a key regulator of tumor progression, to enhance resistance to apoptosis and DNA damage, further supporting its contribution to gastric cancer pathogenesis (Li et al., 2024). Here, PARP9 is linked to neoplasm.